IDI-MRSA (TM) detection test for methicillin-resistant Staphylococcus aureus (MRSA) colonisation - horizon scanning review
NHSC
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
NHSC. IDI-MRSA (TM) detection test for methicillin-resistant Staphylococcus aureus (MRSA) colonisation - horizon scanning review. Birmingham: National Horizon Scanning Centre (NHSC). 2004
Authors' objectives
This study aims to summarise the currently available evidence on the IDI-MRSA (TM) detection test for methicillin-resistant Staphylococcus aureus (MRSA) colonisation.
Authors' conclusions
IDI-MRSA (TM) is a qualitative in vitro real-time polymerase chain reaction (PCR) test for the direct detection of nasal colonisation by methicillin-resistant S. aureus (MRSA). The whole procedure takes approximately 60-75 minutes. The IDI-MRSA test is able to detect MRSA directly from specimens containing a mixture of staphylococci. From 786 nasal specimens collected and screened for MRSA using the IDI-MRSA test, a sensitivity and specificity was determined to be 92.5% and 96.4% respectively. This test has currently been validated for nasal swabs only.
Department of Public Health&Epidemiology, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Tel: +44 121 414 7831; Fax: +44 121 414 2269; Email: c.packer@bham.ac.uk